C-RX

V:RX - BioSyent Inc. - http://www.biosyent.com

20:47:58 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
RX - V	1.9	8.50	·	8.60	0.5	8.51			5.7	47	25	8.51 8.69 8.45	9.26 7.03	15:59:59	Apr 25	15 min RT 2¢
TSX-V - V	1.9	8.50	·	8.60	0.5	8.51			3.8	32	12	8.51 8.69 8.45	9.26 7.03	15:59:59		15 min
NEO ATS - U						8.51			0.1	1	1	8.51 8.51 8.51		14:45:24		15 min
Omega - O						8.69	+0.18	2.1	0.6	5	2	8.69 8.69 8.69		13:08:51		15 min
Pure - P						8.51			0.07	1	2					15 min
CX2 - H						8.51			0.4	3	2	8.51 8.51 8.51		14:45:24		15 min
CXD - D						8.51			0.01		1			Apr 25		15 min
TriAct - M						8.51			0.7	5	5			Sep 11-20		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 25

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:59:59	V	8.51		100	1 Anonymous	79 CIBC	K
15:59:14	V	8.57	0.06	100	80 National Bank	79 CIBC	K
14:45:24	H	8.51		300	1 Anonymous	2 RBC	K
14:45:24	H	8.51		100	1 Anonymous	2 RBC	K
14:45:24	M	8.52	0.01	200	1 Anonymous	1 Anonymous
14:45:24	U	8.51		100	2 RBC	2 RBC	K
13:08:51	V	8.69	0.18	300	85 Scotia	79 CIBC	K
13:08:51	P	8.69	0.18	50	85 Scotia	7 TD Sec	E
13:08:51	M	8.68	0.17	100	85 Scotia	79 CIBC
13:08:51	V	8.68	0.17	100	85 Scotia	79 CIBC	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins

News ReleasesIn The NewsOther

Date ET	Symbol	Price	Type	Headline
2024-04-25 10:13	C:RX	8.40	SEDAR Annual Report803	SEDAR Annual Report
2024-04-15 16:50	C:RX	8.64	News Release200	BioSyent extends licence for RepaGyn, Proktis-M
2024-03-27 18:38	C:RX	8.70	News Release200	BioSyent grants 66,020 RSUs
2024-03-13 17:47	C:RX	8.65	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2024-03-13 17:47	C:RX	8.65	SEDAR MD & A815	SEDAR MD & A
2024-03-13 17:41	C:RX	8.65	News Release200	BioSyent earns $6.46-million in 2023
2024-03-06 16:37	C:RX	8.65	News Release200	BioSyent to release fiscal 2023 results March 13
2024-02-06 16:35	C:RX	8.75	News Release200	BioSyent increases quarterly dividend to 4.5 cents
2024-02-06 16:11	C:RX	8.60	Dividend Declared190	BioSyent to pay 4.5-cent dividend
2023-12-13 16:12	C:RX	8.62	Normal Course Issuer Bid345	BioSyent normal course issuer bid
2023-12-13 11:47	C:RX	8.62	News Release200	BioSyent may buy back up to 650,000 shares under NCIB
2023-11-20 11:02	C:RX	8.30	News Release200	BioSyent begins shipping Gelclair to Canada
2023-11-16 10:23	C:RX	8.00	News Release200	BioSyent earns $2.35-million in Q3 2023
2023-11-16 08:13	C:RX	8.00	SEDAR Interim MD & A813	SEDAR Interim MD & A
2023-11-16 08:12	C:RX	8.00	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2023-11-15 16:39	C:RX	8.00	News Release200	BioSyent to pay four-cent dividend Dec. 15
2023-11-09 13:57	C:RX	8.00	News Release200	BioSyent to release Q3 results Nov. 16
2023-10-18 11:42	C:RX	8.00	News Release200	BioSyent rolls out menopauseinformation website
2023-08-22 16:44	C:RX	7.60	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2023-08-22 16:41	C:RX	7.60	SEDAR Interim MD & A813	SEDAR Interim MD & A